WARSAW, Ind., Oct. 28, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (ZBH), a global medical technology leader, today announced plans for the broad commercial launch of the Z1™ Femoral Hip System ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Zimmer Biomet issued a field safety corrective notice ...
Zimmer Biomet Holdings, Inc (NYSE:ZBH) announced plans to phase out its CPT Hip System by December. The decision comes on the heels of a warning from the U.S. Food and Drug Administration (FDA), ...
This week, FDA issued a safety communication connected to Zimmer Biomet’s CPT Hip System Femoral Stem after finding increased risk of thigh bone fracture — postoperative periprosthetic femoral ...
iTaperloc ® Complete and iG7 ™ Hip System with Iodine Technology inhibits bacterial adhesion and prevents biofilm formation on the implant surface to help address the issue of Periprosthetic Joint ...
(RTTNews) - The U.S. Food and Drug Administration has issued a safety alert about the increased risk of thigh bone fracture after surgery with the use of the Zimmer Biomet CPT Hip System, which was ...
Add Yahoo as a preferred source to see more of our stories on Google. The logo of medical implants maker Zimmer Biomet is seen at a plant in Winterthur (Reuters) - Medtech firm Zimmer Biomet Holdings ...
On Wednesday, Zimmer Biomet Holdings, Inc (NYSE:ZBH) reported third-quarter adjusted EPS of $1.74, up from $1.65 a year ago, in line with the Street estimates. The orthopedic giant reported sales of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results